All Comments by

  1. Edward Koo on Antibodies to beta-amyloid decrease the blood-to-brain transfer of beta-amyloid peptide.
  2. Edward Koo on The Alzheimer's A beta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration.
  3. Ruth Perez on Novel Cell-Based Parkinson's Model Shows Promise
  4. David Holtzman on Antibodies to beta-amyloid decrease the blood-to-brain transfer of beta-amyloid peptide.
  5. David Holtzman on The Alzheimer's A beta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration.
  6. Benjamin Wolozin on An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage.
  7. Bruce Yankner on Dopamine Renders α-Synuclein Toxic to Neurons
  8. David Holtzman on Mutant Proteins—Is it Quality or Quantity that Counts?
  9. Inez Vincent on p53 as Mediator of Oxidative Stress and Inflammation?
  10. Edward Koo on An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage.
  11. Edward Koo on Analysis of tau haplotypes in Pick's disease.
  12. Ruth Perez on Dopamine Renders α-Synuclein Toxic to Neurons
  13. Benjamin Wolozin on Proteasome inhibition causes nigral degeneration with inclusion bodies in rats.
  14. Benjamin Wolozin on Annular alpha-synuclein protofibrils are produced when spherical protofibrils are incubated in solution or bound to brain-derived membranes.
  15. Benjamin Wolozin on Labeling of cerebral amyloid beta deposits in vivo using intranasal basic fibroblast growth factor and serum amyloid P component in mice.